Della Porta et al developed a myelodysplastic syndrome specific comorbidity index (MDS-CI). This can help to determine the risk for a non-leukemic death (NLD). The authors are from the University of Pavia & Fondazione IRCCS Policlinico San Matteo and Heinrich Heine University in Dusseldorf.